Additional file 1: of Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study

  • Cheng Maw Ho (Contributor)
  • Chih-hsin Lee (Contributor)
  • Ming Chia Lee (Contributor)
  • Jun Fu Zhang (Creator)
  • Jann Yuan Wang (Contributor)
  • R. H. Hu (Contributor)
  • P. H. Lee (Contributor)



Figure S1. Illustrative criteria of patient inclusion in the first step. (TIFF 127 kb)
Date made available2018

Cite this